JP2020519250A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519250A5
JP2020519250A5 JP2019558571A JP2019558571A JP2020519250A5 JP 2020519250 A5 JP2020519250 A5 JP 2020519250A5 JP 2019558571 A JP2019558571 A JP 2019558571A JP 2019558571 A JP2019558571 A JP 2019558571A JP 2020519250 A5 JP2020519250 A5 JP 2020519250A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
amino acid
seq
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019558571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519250A (ja
Filing date
Publication date
Priority claimed from GBGB1706781.0A external-priority patent/GB201706781D0/en
Application filed filed Critical
Publication of JP2020519250A publication Critical patent/JP2020519250A/ja
Publication of JP2020519250A5 publication Critical patent/JP2020519250A5/ja
Priority to JP2022202078A priority Critical patent/JP2023027315A/ja
Pending legal-status Critical Current

Links

JP2019558571A 2017-04-28 2018-04-27 副甲状腺ホルモン融合ポリペプチド Pending JP2020519250A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022202078A JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1706781.0A GB201706781D0 (en) 2017-04-28 2017-04-28 Parathyroid hormone fusion polypeptide
GB1706781.0 2017-04-28
PCT/GB2018/051120 WO2018197895A2 (en) 2017-04-28 2018-04-27 Parathyroid hormone fusion polypeptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022202078A Division JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Publications (2)

Publication Number Publication Date
JP2020519250A JP2020519250A (ja) 2020-07-02
JP2020519250A5 true JP2020519250A5 (https=) 2021-06-10

Family

ID=59011076

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019558571A Pending JP2020519250A (ja) 2017-04-28 2018-04-27 副甲状腺ホルモン融合ポリペプチド
JP2022202078A Pending JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022202078A Pending JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Country Status (7)

Country Link
US (2) US11344606B2 (https=)
EP (1) EP3609913A2 (https=)
JP (2) JP2020519250A (https=)
CN (1) CN110546159B (https=)
CA (1) CA3061088A1 (https=)
GB (1) GB201706781D0 (https=)
WO (1) WO2018197895A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide
IL284533B2 (en) * 2019-01-11 2024-02-01 Radius Health Inc Methods for detecting antibodies to neutralizing thyroid hormone (PTH) and thyroid hormone-related peptide (PTHRP) analog
CN111876388A (zh) * 2020-07-24 2020-11-03 赛瑞诚(苏州)生物科技有限公司 一种骨和骨组织靶向外泌体及其制备方法和应用
CN118126197B (zh) * 2024-03-19 2025-02-25 康众(广东)生物医药有限公司 一种重组pth融合蛋白及其构建方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
JPH11285388A (ja) 1998-04-03 1999-10-19 Jcr Pharmaceuticals Co Ltd キメラレセプター発現細胞とその用途
EP2348047A1 (en) 2000-04-21 2011-07-27 New England Medical Center G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
EP1771467A2 (en) 2004-07-26 2007-04-11 Asterion Limited Linkers
KR100700869B1 (ko) 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
CA2930681C (en) 2007-04-09 2019-10-15 The Board Of Trustees Of The University Of Arkansas Fusion protein of collagen-binding domain and parathyroid hormone
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013519699A (ja) 2010-02-16 2013-05-30 ノヴォ ノルディスク アー/エス 因子viii融合タンパク質
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.
GB201104285D0 (en) * 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins
US9579273B2 (en) 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
JP2015504087A (ja) 2012-01-20 2015-02-05 ルピン・リミテッドLupin Limited 安定化pth製剤
AU2014296288B2 (en) * 2013-07-31 2020-02-13 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating thermogenesis using PTH-related and EGF-related molecules
JP6805174B2 (ja) 2015-05-12 2020-12-23 アメリカ合衆国 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むaav分離株及び融合タンパク質
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide

Similar Documents

Publication Publication Date Title
US6051686A (en) Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
JP2020519250A5 (https=)
PE20231309A1 (es) Agonistas duales glp-1/gip
CA2246733C (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
RU2207874C9 (ru) Производное инсулина или его физиологически приемлемая соль, предшественник производного инсулина, днк-последовательность, кодирующая предшественник, вектор экспрессии, содержащий упомянутую днк-последовательность, субстрат, трансформированный упомянутым вектором экспрессии, фармацевтическая композиция с понижающей, соответственно регулирующей уровень глюкозы в крови эффективностью
RU2010133233A (ru) Новые производные инсулина с сильно замедленным профилем время/действие
JP2011509269A5 (https=)
JP5864506B2 (ja) グルコース依存性インスリン分泌刺激ポリペプチドの切り詰められたアナログ
CN105324397A (zh) 胰岛素-肠促胰岛素缀合物
CA2434237A1 (en) Glp-1 fusion proteins
CA2302255A1 (en) Fracture healing using pthrp analogs
AR031701A1 (es) COMPUESTOS ANA LOGOS DEL (GLP-1)-PEPTIDO-1 ANALOGO DEL GLUCAGoN, METODO PARA ESTIMULAR LOS RECEPTORES GLP-1 UTILIZANDO DICHOS COMPUESTOS Y USO DE DICHOS COMPUESTOS EN LA PREPARACION DE MEDICAMENTOS PARA ESTIMULAR LA SECRECION DE INSULINA
JP2002509854A5 (https=)
HRP20110714T1 (hr) Fuzijski proteini analoga glp-1
KR20090119876A (ko) 글루카곤/glp-1 수용체 공동-항진물질
JP2015180647A (ja) ハロゲン安定化インスリン
NZ502592A (en) Exendin agonist peptides and their use in the treatment of type I and II diabetes
RU2010133231A (ru) Новые производные инсулина с чрезвычайно замедленным профилем время/действие
US20220218790A1 (en) Parathyroid hormone fusion polypeptide
JP2010043001A (ja) Glp−1誘導体とその用途
JP2021516222A5 (https=)
US20150353621A1 (en) N-terminal truncated insulin analogues
RU2024106867A (ru) Аффимеры, связывающиеся с неонатальным Fc рецептором
Sami et al. Overproduction of a gastrointestinal hormone, secretin, in Escherichia coli cells and its chemical characterization.
MXPA00001419A (en) Novel exendin agonist compounds